Carlsmed's custom medical devices are entering a competitive market against products from Johnson & Johnson, Globus Medical, and Medtronic plc.

The entities involved

• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
  • Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04
• Globus Medical →

  company

  • Medtronic is ramping up its Hugo RAS system to compete with Intuitive Surgical, while its neuroscience unit faces competitive pressure from Stryker and Globus Medical.Sun 14:58
• Medtronic plc →

  medical device company

  • Wolfe Research upgraded Medtronic's stock rating on July 4, 2025, coinciding with the company announcing the integration of the Affera platform.Sun 14:50
  • MarketBeat listed Danaher, Dexcom, Medtronic, Gilead Sciences, and Boston Scientific as stocks to watch on September 22, 2026.Tue 20:16

Related events

• Medical device sales are up in the U.S., but major players like J&J are facing market headwinds due to the VBP program in China.Jun 7
• MedTech is identified as a soft spot in J&J case.Aug 17
• Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.Aug 28
• Johnson & Johnson is reportedly considering a sale of its orthopedics business unit within DePuy Synthes.Sep 15